Physician Resources

Tools You Can Use

Vaccine Provider Toolkit

Click the icon above to see our COVID-19 vaccine provider toolkit. It includes information on vaccine allocation, storage, billing/coding, enrollment instructions, FAQs, and more.

COVID-19 Testing Sites​

Due to the expansive number of COVID-19 testing centers Alabama now has, we have decided to create a standalone webpage for this information. Please click the icon at the top of this alert to visit.​

Coronavirus News and Information

Vaccine Sites for Physicians

Healthcare workers, including all physicians, are in the first group of people with the opportunity to receive the COVID-19 vaccine. However, because the initial supply of the vaccine will be limited, it is necessary for the Alabama Department of Public Health (ADPH) to prioritize who will receive the initial doses. 
 
The following is a list of physician categories that have been prioritized for the initial doses:
  • Any physician 65 years of age or older with underlying chronic health conditions who has not tested positive for COVID in the last 90 days and who is in direct physical contact with patients.
  • Any health care worker, nurse, PA, or aide 65 years or older with underlying chronic health conditions who have not tested positive for COVID in the last 90 days, who works with a physician and is in direct physical contact with patients.
  • Physicians, nurses, PA’s and aides working in an Urgent Clinic or a primary care office who have not tested positive for COVID in the last 90 days and is in direct physical contact with patients. This does NOT include a practice doing only well visits.
 

Pfizer Vaccine Clinics

Moderna Vaccine Clinics – Hospitals

Moderna Vaccine Clinics – County Health Departments

Moderna Vaccine Clinics – Pharmacies

‘Breakthrough Finding’ Reveals Why Certain COVID Patients Die

In an international study in Science, 10% of nearly 1,000 COVID patients who developed life-threatening pneumonia had antibodies that disable key immune system proteins called interferons. These antibodies — known as autoantibodies because they attack the body itself — were not found at all in 663 people with mild or asymptomatic COVID infections. Only four of 1,227 healthy individuals had the autoantibodies. The study, published on Oct. 23, was led by the COVID Human Genetic Effort, which includes 200 research centers in 40 countries.
 
“This is one of the most important things we’ve learned about the immune system since the start of the pandemic,” said Dr. Eric Topol, executive vice president for research at Scripps Research in San Diego, who was not involved in the new study. “This is a breakthrough finding.”
 
Read the full article on these studies and their findings here.

Genetic Variants of SARS-CoV-2 May Lead to False Negative Results with Molecular Tests

The U.S. Food and Drug Administration (FDA) is alerting clinical laboratory staff and health care providers that false negative results may occur with any molecular test for the detection of SARS-CoV-2 if a mutation occurs in the part of the virus’ genome assessed by that test. 
 
The FDA recommends clinical laboratory staff and health care providers who use molecular tests for the detection of SARS-CoV-2 to be aware that genetic variants of SARS-CoV-2 arise regularly and false-negative test results can occur and consider negative results in combination with clinical observations, patient history, and epidemiological information. 
 
View the full alert from the FDA. If you have questions, contact COVID19DX@fda.hhs.gov.

Quick Resources

BCBS AL Updates:

Crisis Line: 1-833-848-1764

Resources tailored to your setting

COVID-19 News

Stay Up to Date on All Things Coronavirus